One more prescribing rule [See “Rheuminations,” September 2009, p. 6], honored mainly in the breach, in our overspending climate: don’t prescribe an expensive brand when generics are as good or better, especially Nexium (which I have never prescribed) versus omeprazole, Lipitor versus simvastatin (which now costs the VA three cents a pill), and—for rheumatologists who are writing 80% Uloric—allopurinol except for the 10% who might need Uloric.
Search results for: methotrexate
Philadelphia Displays Many Facets of the Healthcare Debate
City of Brotherly Love displays many facets of the healthcare debate
Coding Corner Question
December’s Coding Challenge
Sex Differences & Rheumatoid Arthritis
The beliefs versus the data
The ACR at 75: A Diamond Jubilee
Feting ACR’s 75 Years: This month’s annual meeting recognizes organization’s growth
Risks and Benefits
Physicians must find the delicate balance between treatment and side effects
Practical Medication Management
Take a firm stand in perioperative and pregnant patients with rheumatic disease
Immunizations in Immunocomprised Patients
Vaccines can help minimize certain diseases
Psoriatic Arthritis: From Leeds to the Limelight
Advances in understanding of the disease begin in the 1960s
Drug Updates
Information on New Approvals and Medication Safety
- « Previous Page
- 1
- …
- 93
- 94
- 95
- 96
- 97
- …
- 101
- Next Page »